{
  "company_number": "11579884",
  "name": "Magnitude Biosciences Limited",
  "url": "/company/11579884",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2018-09-20",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "72110",
      "description": "Research and experimental development on biotechnology",
      "section": "M",
      "section_name": "Professional, scientific and technical activities",
      "url": "/sic/72110"
    }
  ],
  "registered_address": {
    "id": 2142527,
    "url": "/address/2142527",
    "line1": "NETPARK PLEXUS",
    "line2": "THOMAS WRIGHT WAY",
    "post_town": "SEDGEFIELD",
    "county": "DURHAM",
    "country": "ENGLAND",
    "postcode": "TS21 3FD"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/11579884",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2027-11-30",
    "last_made_up": "2026-02-28",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/11579884/accounts/2026-02-28",
        "pdf_url": "/company/11579884/accounts/2026-02-28.pdf",
        "made_up_date": "2026-02-28",
        "period_start": "2026-02-28",
        "period_end": "2026-02-28",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "0.21",
        "tangible_fixed_assets": "46248.00",
        "debtors": "171438.00",
        "cash_bank_in_hand": "139978.00",
        "current_assets": "311416.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "70984.00",
        "total_assets_less_current_liabilities": "117232.00",
        "net_assets_liabilities": "117232.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "422.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2026.zip"
      },
      {
        "url": "/company/11579884/accounts/2025-02-28",
        "pdf_url": "/company/11579884/accounts/2025-02-28.pdf",
        "made_up_date": "2025-02-28",
        "period_start": "2025-02-28",
        "period_end": "2025-02-28",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "0.16",
        "tangible_fixed_assets": "44710.00",
        "debtors": "177585.00",
        "cash_bank_in_hand": "159196.00",
        "current_assets": "336781.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-2275.00",
        "total_assets_less_current_liabilities": "42435.00",
        "net_assets_liabilities": "42185.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "347.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2025.zip"
      },
      {
        "url": "/company/11579884/accounts/2024-02-29",
        "pdf_url": "/company/11579884/accounts/2024-02-29.pdf",
        "made_up_date": "2024-02-29",
        "period_start": "2024-02-29",
        "period_end": "2024-02-29",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "14.00",
        "tangible_fixed_assets": "44218.00",
        "debtors": "126119.00",
        "cash_bank_in_hand": "215543.00",
        "current_assets": "341662.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "258689.00",
        "total_assets_less_current_liabilities": "302907.00",
        "net_assets_liabilities": "301643.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "347.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2024.zip"
      },
      {
        "url": "/company/11579884/accounts/2023-02-28",
        "pdf_url": "/company/11579884/accounts/2023-02-28.pdf",
        "made_up_date": "2023-02-28",
        "period_start": "2023-02-28",
        "period_end": "2023-02-28",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "12.00",
        "tangible_fixed_assets": "49331.00",
        "debtors": "161677.00",
        "cash_bank_in_hand": "93738.00",
        "current_assets": "255415.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "199548.00",
        "total_assets_less_current_liabilities": "248879.00",
        "net_assets_liabilities": "246529.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "306.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2023.zip"
      },
      {
        "url": "/company/11579884/accounts/2022-02-28",
        "pdf_url": "/company/11579884/accounts/2022-02-28.pdf",
        "made_up_date": "2022-02-28",
        "period_start": "2022-02-28",
        "period_end": "2022-02-28",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "9.00",
        "tangible_fixed_assets": "51374.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "151087.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "143744.00",
        "total_assets_less_current_liabilities": "195118.00",
        "net_assets_liabilities": "184305.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "184305.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2022.zip"
      },
      {
        "url": "/company/11579884/accounts/2021-02-28",
        "pdf_url": "/company/11579884/accounts/2021-02-28.pdf",
        "made_up_date": "2021-02-28",
        "period_start": "2021-02-28",
        "period_end": "2021-02-28",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": "55384.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "206231.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "203701.00",
        "total_assets_less_current_liabilities": "259085.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "259085.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2021.zip"
      },
      {
        "url": "/company/11579884/accounts/2020-02-29",
        "pdf_url": "/company/11579884/accounts/2020-02-29.pdf",
        "made_up_date": "2020-02-29",
        "period_start": "2020-02-29",
        "period_end": "2020-02-29",
        "entity_name": "Magnitude Biosciences Limited",
        "dormant": false,
        "average_employees": "6.00",
        "tangible_fixed_assets": "7950.00",
        "debtors": null,
        "cash_bank_in_hand": null,
        "current_assets": "164495.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "140923.00",
        "total_assets_less_current_liabilities": "148873.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "148873.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2020.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/11579884/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-09-10",
    "last_made_up": "2026-08-27"
  },
  "officers": [
    {
      "name": "MCFERRAN, Derek Wilson",
      "person_url": "/person/7745139",
      "role": "director",
      "appointed_on": "2025-07-01",
      "resigned_on": null,
      "nationality": "British",
      "occupation": "",
      "source": "stream",
      "retrieved_at": "2026-08-27T13:48:08+00:00"
    },
    {
      "name": "SALEEM, Fozia, Dr",
      "person_url": "/person/7745108",
      "role": "director",
      "appointed_on": "2022-10-03",
      "resigned_on": null,
      "nationality": "British",
      "occupation": "",
      "source": "stream",
      "retrieved_at": "2026-08-27T13:48:08+00:00"
    },
    {
      "name": "WATERMAN, Sally Christina, Dr",
      "person_url": "/person/6224685",
      "role": "director",
      "appointed_on": "2022-02-14",
      "resigned_on": null,
      "nationality": "British",
      "occupation": "",
      "source": "stream",
      "retrieved_at": "2026-08-27T13:48:08+00:00"
    },
    {
      "name": "SAUNTER, Christopher David, Dr",
      "person_url": "/person/7745135",
      "role": "director",
      "appointed_on": "2018-09-20",
      "resigned_on": null,
      "nationality": "British",
      "occupation": "",
      "source": "stream",
      "retrieved_at": "2026-08-27T13:48:08+00:00"
    },
    {
      "name": "O'BRIEN, John",
      "person_url": "/person/7943547",
      "role": "director",
      "appointed_on": "2018-09-20",
      "resigned_on": "2022-06-14",
      "nationality": "British",
      "occupation": "",
      "source": "stream",
      "retrieved_at": "2026-09-04T07:55:05+00:00"
    }
  ],
  "psc": [
    {
      "name": "The Noth East (Erdf) Innovation Fund Limited Partnership",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2019-09-19",
      "ceased_on": null,
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    },
    {
      "name": "Treerunner Holdings Limited",
      "kind": "corporate-entity-person-with-significant-control",
      "person_url": null,
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2022-10-27",
      "ceased_on": "2025-03-31",
      "nationality": "",
      "country_of_residence": "",
      "source": "snapshot"
    },
    {
      "name": "Dr David Weinkove",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/1235336",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-25-to-50-percent",
        "voting-rights-25-to-50-percent",
        "right-to-appoint-and-remove-directors"
      ],
      "notified_on": "2018-09-20",
      "ceased_on": "2018-11-30",
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-09-01",
    "retrieved_at": "2026-09-27T03:26:42.415828+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}